Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients

OBJECTIVE: To develop a population pharmacokinetic model for lopinavir boosted by ritonavir in coronavirus disease 2019 (Covid-19) patients. METHODS: Concentrations of lopinavir/ritonavir were assayed by an accredited LC-MS/MS method. The population pharmacokinetics of lopinavir was described using...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, Jean Claude, Moine, Pierre, Davido, Benjamin, Etting, Isabelle, Annane, Djillali, Larabi, Islam Amine, Simon, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552959/
https://www.ncbi.nlm.nih.gov/pubmed/33048175
http://dx.doi.org/10.1007/s00228-020-03020-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552959/
https://www.ncbi.nlm.nih.gov/pubmed/33048175
http://dx.doi.org/10.1007/s00228-020-03020-w

Ejemplares similares